New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
3 Minute Read
We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
3 Minute Read
As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
2 Minute Read
Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.
4 Minute Read
This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
2 Minute Read
Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.
4 Minute Read
We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.